×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Novan Inc. (NOVN) NASDAQ

$0.09 - (-)

Market Cap: -

As of 07/25/23 12:00 AM EDT. Market closed.

(NOVN)

Novan Inc. (NOVN)
NASDAQ

$0.09
- (-)

Market Cap: -

As of 07/25/23 12:00 AM EDT. Market closed.

Add to Portfolio

novan, inc. is a clinical-stage biotechnology company focused on leveraging nitric oxide’s natural antiviral and immunomodulatory mechanisms of action to treat dermatological and oncovirus-mediated diseases. we believe that our ability to conveniently deploy nitric oxide in a solid form, on demand and in localized formulations allows us the potential to significantly improve patient outcomes in ... read more

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Paula Stafford
Full Time Employees
75
URL
Address
4105 Hopson Rd, North Carolina, Morrisville, 27560-9018.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Paula Stafford
Full Time Employees
75
Address
4105 Hopson Rd, North Carolina, Morrisville, 27560-9018.
PRICE CHART FOR NOVAN INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.13
Previous Close
$0.09
Days Range
$0.08 - $0.14
52 week range
- - -
Volume
7,190,009
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
28,015,371
Open
$0.13
Previous Close
$0.09
Days Range
$0.08 - $0.14
52 week range
- - -
Volume
7,190,009
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
28,015,371
FINANCIAL STATEMENTS FOR NOVAN INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR NOVAN INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
SANDERS MACHELLEDirectorJun 27, 2023 Sale$0.4111,5534,71625,248Jun 27, 2023, 06:30 PM
BIERMAN JAMES LDirectorApr 07, 2022 Buy$3.451,0003,4494,000Apr 11, 2022, 04:15 PM
BIERMAN JAMES LDirectorMar 28, 2022 Buy$3.451,0003,4503,000Mar 30, 2022, 05:23 PM
BIERMAN JAMES LDirectorMar 25, 2022 Buy$3.552,0007,0902,000Mar 28, 2022, 05:01 PM
PALMOUR JOHN WDirectorMar 18, 2022 Buy$3.6310,00036,35069,356Mar 22, 2022, 05:26 PM
GAY JOHN M.Chief Financial OfficerMar 18, 2022 Buy$3.501,0003,5002,500Mar 22, 2022, 05:25 PM
PALMOUR JOHN WDirectorMar 16, 2022 Buy$3.345,00016,68554,356Mar 18, 2022, 05:52 PM
PALMOUR JOHN WDirectorMar 17, 2022 Buy$3.345,00016,70559,356Mar 18, 2022, 05:52 PM
STAFFORD PAULA BPresident and CEOMar 26, 2021 Buy$1.4370,000100,100150,693Mar 29, 2021, 04:07 PM
Malin Life Sciences Holdings Ltd10% OwnerJul 02, 2019 Sale$2.756,28717,2892,598,485Jul 02, 2019, 09:45 PM
Malin Life Sciences Holdings Ltd10% OwnerJul 01, 2019 Sale$2.749132,5022,604,772Jul 02, 2019, 09:45 PM
Malin Life Sciences Holdings Ltd10% OwnerJun 28, 2019 Sale$2.6917,80047,8822,605,685Jul 02, 2019, 09:45 PM
Martin G. KellyChief Executive OfficerMay 29, 2019 Buy$1.971,5002,95545,000May 30, 2019, 05:25 PM
Martin G. KellyChief Executive OfficerMay 28, 2019 Buy$2.153,5007,52543,500May 29, 2019, 09:00 AM
PALMOUR JOHN WDirectorMay 24, 2019 Buy$2.2020,00044,000293,568May 29, 2019, 08:59 AM
Geer W KentDirectorMay 21, 2019 Buy$1.905,0009,50015,828May 23, 2019, 08:32 AM
INGRAM ROBERT ALEXANDERDirectorMay 22, 2019 Buy$2.2150,000110,500169,777May 23, 2019, 08:31 AM
NOVAK ANDREWVP, Accounting and Bus OpsMay 17, 2019 Buy$1.475,4007,9386,700May 21, 2019, 04:54 PM
GAY JOHN M.VP, Finance & Corp. ControllerMay 17, 2019 Buy$1.5014,90022,35015,000May 21, 2019, 04:53 PM
STAFFORD PAULA BPresident and COOMay 17, 2019 Buy$1.496931,033693May 21, 2019, 04:52 PM
STAFFORD PAULA BPresident and COOMay 20, 2019 Buy$1.9280,000153,60080,693May 21, 2019, 04:52 PM
Martin G. KellyChief Executive OfficerMay 17, 2019 Buy$1.4340,00057,20040,000May 21, 2019, 04:51 PM
Martin G. KellyChief Executive OfficerMay 17, 2019 Buy$1.4320,00028,60060,000May 21, 2019, 04:51 PM
INGRAM ROBERT ALEXANDERDirectorSep 28, 2018 Buy$2.8450,000142,000119,777Oct 01, 2018, 04:34 PM
Martin G. KellyChief Executive OfficerSep 26, 2018 Buy$2.7310,00027,30040,000Sep 27, 2018, 04:24 PM
PALMOUR JOHN WDirectorAug 22, 2018 Buy$2.6620,00053,200273,568Aug 24, 2018, 08:43 AM
HUNTER JEFF NEVP & Chief Business OfficerAug 22, 2018 Option Exercise$1.1211,66713,067186,666Aug 24, 2018, 08:41 AM
Martin G. KellyChief Executive OfficerAug 21, 2018 Buy$2.7130,00081,30030,000Aug 23, 2018, 04:32 PM
Hodges William LInterim Chief Financial OfficeSep 15, 2017 Option Exercise$6.035,00030,1505,000Sep 18, 2017, 04:35 PM
INGRAM ROBERT ALEXANDERDirectorAug 29, 2017 Buy$4.708,46539,78569,777Aug 29, 2017, 04:37 PM
INGRAM ROBERT ALEXANDERDirectorAug 25, 2017 Buy$4.253,53515,02461,312Aug 29, 2017, 04:37 PM
PALMOUR JOHN WDirectorAug 23, 2017 Buy$3.9912,00047,880253,568Aug 25, 2017, 04:33 PM
Malin Life Sciences Holdings Ltd10% OwnerSep 26, 2016 Buy$11.00800,0008,800,0002,623,485Sep 28, 2016, 06:27 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
SANDERS MACHELLEDirector06/27/20234,716
BIERMAN JAMES LDirector04/07/20223,449
BIERMAN JAMES LDirector03/28/20223,450
BIERMAN JAMES LDirector03/25/20227,090
PALMOUR JOHN WDirector03/18/202236,350
GAY JOHN M.Chief Financial Officer03/18/20223,500
PALMOUR JOHN WDirector03/16/202216,685
PALMOUR JOHN WDirector03/17/202216,705
STAFFORD PAULA BPresident and CEO03/26/2021100,100
Malin Life Sciences Holdings Ltd10% Owner07/02/201917,289
Malin Life Sciences Holdings Ltd10% Owner07/01/20192,502
Malin Life Sciences Holdings Ltd10% Owner06/28/201947,882
Martin G. KellyChief Executive Officer05/29/20192,955
Martin G. KellyChief Executive Officer05/28/20197,525
PALMOUR JOHN WDirector05/24/201944,000
Geer W KentDirector05/21/20199,500
INGRAM ROBERT ALEXANDERDirector05/22/2019110,500
NOVAK ANDREWVP, Accounting and Bus Ops05/17/20197,938
GAY JOHN M.VP, Finance & Corp. Controller05/17/201922,350
STAFFORD PAULA BPresident and COO05/17/20191,033
STAFFORD PAULA BPresident and COO05/20/2019153,600
Martin G. KellyChief Executive Officer05/17/201957,200
Martin G. KellyChief Executive Officer05/17/201928,600
INGRAM ROBERT ALEXANDERDirector09/28/2018142,000
Martin G. KellyChief Executive Officer09/26/201827,300
PALMOUR JOHN WDirector08/22/201853,200
HUNTER JEFF NEVP & Chief Business Officer08/22/201813,067
Martin G. KellyChief Executive Officer08/21/201881,300
Hodges William LInterim Chief Financial Office09/15/201730,150
INGRAM ROBERT ALEXANDERDirector08/29/201739,785
INGRAM ROBERT ALEXANDERDirector08/25/201715,024
PALMOUR JOHN WDirector08/23/201747,880
Malin Life Sciences Holdings Ltd10% Owner09/26/20168,800,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING FOR NOVAN INC
STOCK BUYBACKS FOR NOVAN INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2023
12/31/2022
6.56%
1Q
03/31/2023
09/30/2022
6.76%
2Q
03/31/2023
06/30/2022
29.19%
3Q
03/31/2023
03/31/2022
38.70%
4Q
03/31/2023
12/31/2021
38.66%
5Q
03/31/2023
09/30/2021
38.81%
6Q
Load More

Period of Report: 03/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2022
6.56%
1Q
09/30/2022
6.76%
2Q
06/30/2022
29.19%
3Q
03/31/2022
38.70%
4Q
12/31/2021
38.66%
5Q
09/30/2021
38.81%
6Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR NOVAN INC
LOADING...